Idogen's Historical Milestones - Idogen
Trading Direkt analyserar bolagen på Spotlight 2019-06-19: Touchtech & Idogen - YouTube
Idogen AB Interim report
Idogen AB (publ) Corp. Reg. No.
Idogen's IDO 8 granted orphan drug designation in the USA - Idogen
Biostock intervjuar Idogens VD Anders Karlsson om kvartalsrapport Q4 samt företrädesemissionen - IPO.se
Idogen handelsstoppad på Spotlight | Analysguiden - Analys, Börs, Bolagsfakta - användbart verktyg för investerare
Idogen AB (publ) Corp. Reg. No.
Idogen AB Interim report Idogen AB Interim report
Annual Report
Idogen's Historical Milestones - Idogen
Idogen files patent application for new tolerogenic cell therapy
PRESS RELEASE IDOGEN AB
Annual Report
Idogen's Historical Milestones - Idogen
Idogen publishes prospectus in connection with the forthcoming rights issue - Nordic Life Science – the leading Nordic life science news service
Idogen's Historical Milestones - Idogen
Idogen's cell technology successfully advanced to large-scale production - Idogen
Idogen extends the project portfolio to projects in autoimmune diseases - Idogen
